# Major Recall Alert: directCHECK™ Whole Blood Control Recalled Due to Incorrect QC Ranges
If you use **directCHECK™ Whole Blood Control**, a recent recall has been issued that could directly affect the accuracy of your lab results. The recall pertains to **lot A6DLA001** of **DCGLR-2**, which was found to produce consistently elevated results due to an error in testing. This occurred as the lot was tested on an incorrect instrument platform, leading to the development and release of **incorrect Quality Control (QC) ranges** on the accompanying performance range card.
Read on for crucial details about this recall and how to ensure the safety and reliability of your operations.
---
## Why This Recall is Important
Quality Control (QC) products like **directCHECK™ Whole Blood Control** are essential in laboratories for ensuring the accuracy and reliability of diagnostic test results. Laboratories worldwide rely on these controls to monitor system performance and deliver reliable patient data.
However, the affected lot (**A6DLA001**) included incorrect QC ranges due to a **process error**. This issue could lead to misinterpretation of test results or potentially incorrect decision-making in healthcare settings. It’s vital that labs promptly address this issue to maintain data integrity and prevent errors that could impact patient outcomes.
---
### Details of the Recall
The recall focuses on the following specifics:
- **Product Name**: directCHECK™ Whole Blood Control
- **Lot Number**: A6DLA001
- **Issue Identified**: Consistently elevated results caused by testing the lot on the wrong instrument platform.
- **Error Outcome**: Incorrect QC ranges were printed on the performance range card distributed with this lot.
- **Category**: CAN – Medical Diagnostics and Testing Control Material
- **Date Announced**: October 20, 2023
To verify that your lab is not affected, check whether you’re using **directCHECK™ Whole Blood Control DCGLR-2, lot A6DLA001**.
For official details, visit the [Government of Canada Recall Page](https://recalls-rappels.canada.ca/en/alert-recall/directchecktm-whole-blood-control).
---
### What You Should Do
If you’re using the affected **directCHECK™ Whole Blood Control (lot A6DLA001)**, here’s what you need to do immediately:
1. **Stop Use**: Cease using **lot A6DLA001** and quarantine all remaining quantities of the affected control material.
2. **Verify QC Ranges**: Review any results generated using this lot, as elevated QC data could compromise accuracy.
3. **Contact Manufacturer**: Reach out to your supplier or the product manufacturer for further instructions on returning or replacing the affected product.
4. **Inform Staff**: Notify all team members about this recall to ensure no further use of the defective lot.
Staying proactive is key to ensuring both patient safety and compliance with regulatory standards.
---
### Stay Safe – Get Instant Recall Alerts
Product recalls like this highlight the importance of having access to timely and accurate recall information. Stay informed about the latest updates in product recalls for medical, food, and consumer goods with the **MyRecalls** app.
With MyRecalls, you can:
- Get real-time alerts about critical recalls.
- Set up personalized notifications based on the categories you care about.
- Access detailed instructions on resolving recalls.
🚨 **Stay one step ahead – [Download the MyRecalls App Today!](https://myrecalls.app/)**
---
Monitoring recalls and taking immediate action is essential for ensuring safety and operational accuracy in your lab. For more information, visit the official [Government of Canada Recall Notice](https://recalls-rappels.canada.ca/en/alert-recall/directchecktm-whole-blood-control).
Don’t wait—protect your lab, your patients, and your processes today.